Почетна › Рак на бели дробови со не-мали клетки › Вашингтон › Tacoma
Клинички испитувања за Рак на бели дробови со не-мали клетки во Tacoma, WA
20 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Tacoma (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Се регрутираФаза 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · на 26 милји
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Се регрутираФаза 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · на 8 милји
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · на 8 милји
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Се регрутираФаза 3
- American Oncology Network Vista Oncology Division-West office, Olympia · на 26 милји
- American Oncology Network Vista Oncology Division-East office, Olympia · на 26 милји
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Се регрутираФаза 3
- Vista Oncology Inc PS, Olympia · на 26 милји
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Vista Oncology, Olympia · на 26 милји
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Се регрутираФаза 3
- American Oncology Network Vista Oncology Division-West office, Olympia · на 26 милји
- American Oncology Network Vista Oncology Division-East office, Olympia · на 26 милји
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Се регрутираФаза 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
Се регрутираНабљудувачка студија
- Northwest Medical Specialties (NWMS), Tacoma
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Се регрутираФаза 3
- Research Site, Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Се регрутираФаза 3
- Local Institution - 0499, Lacey · на 23 милји
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Се регрутираФаза 3
- Research Site, Tacoma
- Research Site, Olympia · на 26 милји
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · на 26 милји
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Се регрутираФаза 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Се регрутираФаза 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Се регрутираФаза 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Се регрутираФаза 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · на 8 милји
- и уште 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Се регрутираФаза 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · на 8 милји
- MultiCare Regional Cancer Center, Puyallup · на 8 милји
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Се регрутираФаза 2
- USA09-0, Puyallup · на 8 милји
BostonGene and Exigent Genomic INsight Study
Се регрутираНабљудувачка студија
- Northwest Medical Specialities, Puyallup · на 8 милји
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY121 студија
- Arlington, VA104 студии
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH57 студии
- Washington, DC55 студии
Други студии во Tacoma
- Рак на дојка18 студии
- Улцерозен колитис15 студии
- Множен миелом13 студии
- Рак на простата11 студии
- Кронова болест11 студии
- Колоректален карцином9 студии
- Метастатски карцином9 студии
- Меланом7 студии
- Карцином на јајниците7 студии
- Рак на стомакот6 студии
- Рак на езофагус6 студии
- Рак (сите типови)6 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.